The newly developed COVID-19 vaccines have established a safe profile, yet some
individuals experience a wide range of adverse events. Recently, reactivation of varicella …

Introduction Although the COVID‐19 vaccination is deemed safe, exact incidence and
nature if adverse effects, particularly dermatological ones, are still unknown. Objective To …

Abstract Coronavirus 2019 (COVID-19), caused by the pathogen SARS-CoV-2, was
declared a pandemic in March 2020. Recently, studies have discussed reports of patients …

Background Case reports have described herpes zoster (HZ) in patients with coronavirus
disease 2019 (COVID-19). However, this constitutes low-quality evidence for an association …

Background: Varicella zoster virus (VZV) has been implicated in Alzheimer's disease (AD),
and vaccination against shingles, caused by VZV, has been found to decrease the risk of …

Introduction Varicella zoster virus (VZV) reactivation has been reported following vaccination
for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but the real extent …

The long‐term risk of herpes zoster (HZ) after recovery from a SARS‐CoV‐2 infection is
unclear. This retrospective cohort study assessed the risk of HZ in patients following a …

Objectives Herpesviruses are ubiquitous and after primary infection they establish lifelong
latency. The impairment of maintaining latency with short-term or long-term consequences …

Herpes zoster (HZ) is caused by reactivation of the latent varicella zoster virus (VZV)
following decline in cell‐mediated immunity. All over the world, in the past couple of years …

In this article we review complications to the peripheral nervous system that occur as a
consequence of viral infections, with a special focus on complications of severe acute …